Can-Fite BioPharma Ltd. Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit
Can-Fite BioPharma Ltd. (CANF) reported Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit of $4.66 per share for the 12-month period ending 2019-12-31, per its 6-K filed 2020-06-01.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit · last filed 2020-06-01
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit 12 month |
|---|---|
| 2019-12-31 | $4.66 6-K · filed 2020-06-01 |
| 2018-12-31 | $4.66 6-K · filed 2020-06-01 |
| 2017-12-31 | $4.66 6-K · filed 2020-06-01 |